BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 33389010)

  • 1. Early hearing improvement predicts the prognosis of idiopathic sudden sensorineural hearing loss.
    Shimanuki MN; Shinden S; Oishi N; Suzuki N; Iwabu K; Kitama T; Kida A; Sakamoto K; Ogawa K
    Eur Arch Otorhinolaryngol; 2021 Nov; 278(11):4251-4258. PubMed ID: 33389010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Acetylcysteine combined with prednisolone treatment shows better hearing outcome than treatment with prednisolone alone for patients with idiopathic sudden sensorineural hearing loss: a retrospective observational study.
    Kouka M; Bevern N; Bitter J; Guntinas-Lichius O
    Eur Arch Otorhinolaryngol; 2024 Jan; 281(1):107-116. PubMed ID: 37392235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
    Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
    Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in elderly patients after an intra-tympanic steroid injection for idiopathic sudden sensorineural hearing loss.
    Chen SL; Hu CY; Chan KC; Chin SC; Ho CY
    Am J Otolaryngol; 2022; 43(5):103528. PubMed ID: 35691052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic model for predicting hearing recovery in idiopathic sudden sensorineural hearing loss.
    Cvorović L; Deric D; Probst R; Hegemann S
    Otol Neurotol; 2008 Jun; 29(4):464-9. PubMed ID: 18434930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and prognosis of low frequency sensorineural hearing loss without vertigo.
    Jung AR; Kim MG; Kim SS; Kim SH; Yeo SG
    Acta Otolaryngol; 2016; 136(2):159-63. PubMed ID: 26479582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminant Analysis of the Prognostic Factors for Hearing Outcomes in Patients with Idiopathic Sudden Sensorineural Hearing Loss.
    Askar AA; Ghonim MR; Shabana YK
    J Int Adv Otol; 2023 Jun; 19(3):162-168. PubMed ID: 37272631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distortion product otoacoustic emissions as a prognostic factor for idiopathic sudden sensorineural hearing loss.
    Chao TK; Chen TH
    Audiol Neurootol; 2006; 11(5):331-8. PubMed ID: 16983184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vertigo as a prognostic sign in sudden sensorineural hearing loss.
    Ben-David J; Luntz M; Podoshin L; Sabo E; Fradis M
    Int Tinnitus J; 2002; 8(2):127-8. PubMed ID: 14763225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of systemic high-dose dexamethasone therapy for idiopathic sudden sensorineural hearing loss.
    Egli Gallo D; Khojasteh E; Gloor M; Hegemann SC
    Audiol Neurootol; 2013; 18(3):161-70. PubMed ID: 23446332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivariate analysis of prognostic factors for idiopathic sudden sensorineural hearing loss in children.
    Chung JH; Cho SH; Jeong JH; Park CW; Lee SH
    Laryngoscope; 2015 Sep; 125(9):2209-15. PubMed ID: 25689850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic sudden sensorineural hearing loss in children.
    Chen YS; Emmerling O; Ilgner J; Westhofen M
    Int J Pediatr Otorhinolaryngol; 2005 Jun; 69(6):817-21. PubMed ID: 15885335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular and cervical vestibular-evoked myogenic potentials in idiopathic sudden sensorineural hearing loss (ISSHL) without vertigo: VEMPs in ISSHL.
    Quaranta N; Longo G; Dadduzio S; Squeo V; Scarano E; Picciotti PM
    Eur Arch Otorhinolaryngol; 2020 Feb; 277(2):409-414. PubMed ID: 31773241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Intratympanic Steroid on Idiopathic Sudden Sensorineural Hearing Loss: An Analysis of Cases With Negative Prognostic Factors.
    Suzuki H; Kawaguchi R; Wakasugi T; Do BH; Kitamura T; Ohbuchi T
    Am J Audiol; 2019 Jun; 28(2):308-314. PubMed ID: 31046392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inpatient treatment of patients with idiopathic sudden sensorineural hearing loss: a population-based healthcare research study.
    Heuschkel A; Geißler K; Boeger D; Buentzel J; Esser D; Hoffmann K; Jecker P; Mueller A; Radtke G; Guntinas-Lichius O
    Eur Arch Otorhinolaryngol; 2018 Mar; 275(3):699-707. PubMed ID: 29330597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of idiopathic sudden sensorineural hearing loss using pulse therapy: a prospective, randomized, double-blind clinical trial.
    Westerlaken BO; de Kleine E; van der Laan B; Albers F
    Laryngoscope; 2007 Apr; 117(4):684-90. PubMed ID: 17415139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratympanic methylprednisolone administration promotes the recovery of idiopathic sudden sensorineural hearing loss: a retrospective case-control study.
    Jiang K; Li S; Cheng L; Yang J
    Acta Otolaryngol; 2018 Nov; 138(11):998-1003. PubMed ID: 30465620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral steroid treatment for idiopathic sudden sensorineural hearing loss.
    Chen WT; Lee JW; Yuan CH; Chen RF
    Saudi Med J; 2015 Mar; 36(3):291-6. PubMed ID: 25737170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Framingham Risk Score as a Prognostic Predictor of Sudden Sensorineural Hearing Loss: A Preliminary Study.
    Chang YS; Choi JE; Ahn J; Ryu NG; Moon IJ; Hong SH; Cho YS; Chung WH
    Ann Otol Rhinol Laryngol; 2017 May; 126(5):382-387. PubMed ID: 28397567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study.
    Xenellis J; Papadimitriou N; Nikolopoulos T; Maragoudakis P; Segas J; Tzagaroulakis A; Ferekidis E
    Otolaryngol Head Neck Surg; 2006 Jun; 134(6):940-5. PubMed ID: 16730534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.